A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Method for Islet Transplantation to the Omentum in Mouse

11.5K views

⸱

DOI:

10.3791/57160

⸱

January 7th, 2019

 ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

A method for the omental transplantation of islets in a mouse is introduced. The isolated islets are mixed with hydrogel and the mixture is placed into the omental pouch of a diabetic mouse. Then, the blood glucose is monitored, and immuno-histochemical analysis is performed.

Abstract

Islet transplantation has been proposed to be a potential treatment for type 1 diabetes. Recent compelling evidence indicates that intravascular islet infusion is far from ideal and therefore, the omentum is re-emerging as a potentially valuable site for islet transplantation. This experiment requires the isolation of high quality islets and the implantation of the islets to the diabetic recipients. Transplantation to the omentum requires surgical steps that can be better demonstrated visually. Here, the detailed steps for this procedure are presented. Two methods of mixing the isolated islets with hydrogel before placing the mixture into the omental pouch of diabetic mice are described here. Different hydrogels are used for the different conditions. Blood glucose levels of diabetic mouse recipients of syngeneic islets in the omentum were monitored for up to 35 days. Some animals were sacrificed after 14 days to perform immuno-histochemical analysis. This pre-clinical transplantation approach can be used as preliminary data leading up to translation to clinical transplantation.

Introduction

According to the International Diabetes Federation (IDF), diabetes mellitus currently affects 382 million people, with a projected increase to 592 million people by 20351. In both allogeneic and xenogeneic islet transplantation, systemic immunosuppressive therapy is necessary. Without immunosuppression, immune rejection is a major cause of graft loss2. There is also a significant problem of transplanted islet loss due to the instant blood mediated inflammatory reaction (IBMIR)3,4. However, even in the absence of an immune response such as in syngeneic or auto-tra....

Access restricted. Please log in or start a trial to view this content.

Protocol

All mice used in this study were obtained from the Medical Animal Center of Guangdong Province. The use of animals was approved by the Ethics Review Committee of Shenzhen Second People's Hospital, in accordance with the principles of animal welfare.

1. Islet Transplantation to the Omentum

NOTE: This protocol requires 2 persons to accomplish.

  1. Assemble surgical materials which are listed in Table 1. Prepare aseptic field in surgical area with sterile materials such as drapes and disposables and maintain aseptic conditions throughout surgery. Sterilize all surgical instruments. Wear ....

Access restricted. Please log in or start a trial to view this content.

Results

Post-digestive state of the pancreas is shown in Figure 1A. Purified islets are shown in Figure 1B. Dithizone staining and viability testing of the islets are shown in Figure 2. The main steps of the islet transplantation to the omentum are shown in Figure 3. The blood glucose levels of the recipients after omental transplantation are shown in Figure.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Islet transplantation to the liver via the portal vein is the most commonly used method of islet transplantation in humans, but there are still efficiency and safety concerns such as portal vein thrombosis and liver steatosis17. Recent studies show that the omentum may be a suitable alternative to the liver, but more research needs to be conducted prior to clinical translation12,14,18,

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors report no conflicts of interest.

Acknowledgements

Some of the authors of this work were supported in part by grants from National Key R&D Program of China (2017YFC1103704), Sanming Project of Medicine in Shenzhen (SZSM201412020), Fund for High Level Medical Discipline Construction of Shenzhen (2016031638), Shenzhen Foundation of Science and Technology (JCJY20160229204849975, GJHZ20170314171357556, JCYJ20160425110110658), Shenzhen Foundation of Health and Family Planning Commission (SZXJ2017021).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Equipment
5 inch (12-13 cm) ScissorsRWD Life Science S12030-11
Fine ForcepsRWD Life ScienceF11010-13
Small wound clipsRWD Life ScienceR33003-01
AcutenaculumRWD Life ScienceF31044-13
2 pair tissue forcepsRWD Life Science F13023-10
4-0 Suture with needleChenghe, China17094
200 μL Pipette and tipsGilsonPN11
One Touch ultraeasy Basic blood glucose monitoring system  Johnson & Johnson33391713
razor bladePhilipsHC1099/15
Material and animals
Pentobarbital SodiumSigmaaldrich.comP3761For anesthesia 
Hydrogel bdbiosciences.com356234Basement Membrane Matrix
Fibrin-Thrombin Hydrogel Baxter.com1501250Components clot when mixed
70% EthanolYingniu medical, Anhui, China23170608
IodophorLierkang medical technology, Shangdong, China170521
Normal salineBaxter.com2B1324
CephalosporinLukang medical, Shangdong, China150303
CefazolinBaxter.com2G3508
lubricant eye ointmentMajor Pharmaceuticals203964
streptozotocinSigmaaldrich.comS0130
collagenase Type VSigmaaldrich.comC9262
CMRL-1066 mediacelltrans, Wenzhou, ChinaX018D1
histopaqueSigmaaldrich.com10771density gradient
PE50 tubingBraintreesci.comPE50 100 FTPolyethylene .023" x .038
Calcein AMSigmaaldrich.comC1359
Propidium iodideSigmaaldrich.comP4864
optimal cutting temperature compound (OCT)Tissue-Tek; Miles, Naperville, IL4583embedding medium
insulin antibodyCell Signaling Technology, Danvers, MA 019238138S
hematoxylin staining mediaCell Signaling Technology, Danvers, MA 0192314166S
eosin staining mediaBeyotime Biotech, ChinaC0109
DAPIThermo Fisher Scientific Inc. D1306
C57Bl/6 MiceMedical Animal Center of Guangdong Province/
Fetal Bovine SerumGE Healthcare Life SciencesSH30084
T175 flasksFalcon353112
1.5 mL Snap-top tubesAxygenMCT-150-C

References

  1. Guariguata, L., et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice. 103 (2), 137-149 (2014).
  2. Bellin, M. D., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Omentum TransplantationHydrogel MixingIslet IsolationSurgical ProcedureBlood Glucose MonitoringImmuno-histochemical AnalysisDAPI StainingInsulin Antibody StainingH&E Staining